Skip to content

Clinical trials

Phase 3 Pancreatic Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 3 Country / region: France Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20052
20063
20073
20083
20092
20114
20131
20144
20151
20163
20171
20181
20191
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated9
Recruiting3
Unknown status3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GERCOR - Multidisciplinary Oncology Cooperative Group4
AB Science2
Celgene2
Eli Lilly and Company2
Incyte Corporation2
Institut Paoli-Calmettes2
Revolution Medicines, Inc.2
Sanofi2
Amgen1
Arcus Biosciences, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms39
Adenocarcinoma5
Neoplasms5
Endocrine Gland Neoplasms3
Neoplasm Metastasis3
Digestive System Diseases2
Digestive System Neoplasms2
Endocrine System Diseases2
Neoplasms by Site2
Pancreatic Diseases2

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.